Pharma penny stock under Rs 40 bags new order worth USD 1,38,075 from Taha Drugs & Chemicals Co. Ltd

The stock is up 11.15 per cent from its 52-week low of Rs 35.70 per share..

Shelter Pharma Limited has secured a significant international order from Sudan-based Taha Drugs & Chemicals Co. Ltd for Nutraceutical Capsules and Tablets. This fixed-cost order, valued at USD 1,38,075, is expected to be executed within the next two months.

Shelter Pharma Limited is a prominent pharmaceutical and nutraceutical company renowned for its dedication to research, innovation and quality. Established to provide accessible and effective healthcare solutions, the company has consistently delivered products that meet the highest industry standards. Their state-of-the-art facilities, world-class team of experts and commitment to ethical practices have earned them a reputation of trust in the industry. Shelter Pharma's mission is to promote well-being and health through innovative, high-quality nutraceuticals.

On Monday, shares of Shelter Pharma Ltd surged 3.06 per cent to Rs 39.68 per share from its previous closing of Rs 38.50 per share. The stock’s 52-week high is Rs 69.70 per share and its 52-week low is Rs 35.70 per share. The stock falls under S&P BSE SME IPO with a lot size of 3,000 shares.

The company has a market cap of Rs 45 crore. The company’s current debt is Rs 1.11 crore which is 2.5 per cent of the market cap. The promoters own more than half of the company's shares, with 52.32 per cent while the general public owns the rest, with 47.68 per cent as of March 2025. There are 1,153 public shareholders as of March 2025. The shares of the company have an ROE of 25 per cent and an ROCE of 33 per cent. The stock is up 11.15 per cent from its 52-week low of Rs 35.70 per share.

Disclaimer: The article is for informational purposes only and not investment advice.